Cyclosporine Effects on Pediatric Kidney Recipients

Author Information
Article Notes and Dates
To Cite : Hami M. Cyclosporine Effects on Pediatric Kidney Recipients, Nephro-Urol Mon. 2012 ;4(2):491-492. doi: 10.5812/numonthly.2659.
  • 1. Beiraghdar F, Rostami Z, Einollahi B. Cyclosporine through and 2 hour post dose monitoring and its contributing factors among pediatric kidney recipients. Nephro-Urol Mon. 2012; 3(4): 296-300
  • 2. Pourfarziani V, Nemati E, Taheri S, Khoddami-Vishte HR, Azizabadi Farahani M. Satisfactory outcome despite low 2-hour postdose cyclosporine level in Iranian kidney recipients. Iran J Kidney Dis. 2008; 2(2): 99-101[PubMed]
  • 3. Bazargani Z, Derakhshan A, Basiratnia M. A comparison between the levels of cyclosporine C0 and C2 in children undergoing renal transplantation. Iran Red Cres Med J. 2007; 9(2): 63-8
  • 4. Kunzendorf U, Hohenstein B, Oberbarnscheid M, Muller E, Renders L, Schott GE, et al. Duration of donor brain death and its influence on kidney graft function. Am J Transplant. 2002; 2(3): 292-4[DOI][PubMed]
  • 5. Krajewska M, Koscielska-Kasprzak K, Weyde W, Drulis-Fajdasz D, Madziarska K, Mazanowska O, et al. Impact of donor-dependent genetic factors on long-term renal graft function. Transplant Proc. 2009; 41(8): 2978-80[DOI][PubMed]
  • 6. Hami M, Mojahedi MJ, Naghibi M, Shakeri MT, Sharifipour F. Cyclosporine trough levels and its side effects in kidney transplant recipients. Iran J Kidney Dis. 2010; 4(2): 153-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Nephro-Urology Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check